Sun Pharma buys Novartis prescription brands in Japan

31-03-2016

Sun Pharma buys Novartis prescription brands in Japan

Marques / Shutterstock.com

India-based pharmaceutical company Sun Pharmaceutical has acquired 14 prescription brands from Novartis in Japan for $293 million.


Sun Pharmaceutical, Novartis, Dilip Shanghvi, patent, portfolio, prescription brands, marketing

LSIPR